Voleon Capital Management LP Invests $375,000 in The Clorox Company $CLX

Key Points

• Voleon Capital Management LP has acquired a new stake in The Clorox Company by purchasing 2,547 shares, valued at approximately $375,000.
• Clorox recently announced a quarterly dividend increase to $1.24 per share, reflecting a positive change from its previous dividend of $1.22, with a dividend yield of 3.9%.
• Several analysts have reduced their price targets for Clorox, with the consensus price target now at $142.18, indicating differing outlooks among analysts with ratings ranging from "Buy" to "Sell."

Voleon Capital Management LP acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,547 shares of the company's stock, valued at approximately $375,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wood Tarver Financial Group LLC acquired a new position in Clorox during the fourth quarter worth $31,000. GW&K Investment Management LLC grew its holdings in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after acquiring an additional 208 shares during the period. Roble Belko & Company Inc grew its holdings in Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock worth $53,000 after acquiring an additional 211 shares during the period. Menard Financial Group LLC purchased a new stake in Clorox during the fourth quarter worth $63,000. Finally, IMA Advisory Services Inc. purchased a new stake in Clorox during the first quarter worth $58,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Trading Down 0.5%

Shares of Clorox stock traded down $0.66 during trading hours on Friday, reaching $123.75. The stock had a trading volume of 1,519,075 shares, compared to its average volume of 1,811,479. The firm has a 50 day simple moving average of $124.27 and a two-hundred day simple moving average of $132.44. The firm has a market capitalization of $15.14 billion, a price-to-earnings ratio of 18.98, a P/E/G ratio of 1.00 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were issued a $1.24 dividend. This is a positive change from Clorox's previous quarterly dividend of $1.22. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox's dividend payout ratio (DPR) is 76.07%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.57% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on CLX. Barclays decreased their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Citigroup restated a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a report on Monday. Jefferies Financial Group dropped their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Finally, UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of "Reduce" and a consensus price target of $142.18.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.